News 10.01.2024 Zurich/Schlieren ZH - The city of Zurich is joining the Bio-Technopark Schlieren-Zurich as a member. The innovative strength of the companies and researchers is expected to create sustainable jobs in the Zurich economic region. The City of Zurich will join the Bio-Technopark Schlieren-Zurich as a member, according to a LinkedIn post...
News 08.01.2024 Newton, Mass., USA & Wädenswil, Switzerland, January 5, 2024 — GlycoEra AG, a pioneering company advancing a pipeline of extracellular protein degraders for the treatment of autoimmune disorders, today announced the expansion of its Series A financing with an investment from Bristol Myers Squibb (BMS). BMS joins existing investors, including...
News 08.01.2024 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced it will present a business overview...
News 07.01.2024 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., and PARIS, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a pioneer in...
News 05.01.2024 Zurich-Schlieren, Switzerland, January 5th, 2024 Swiss biotech start-up Topadur Pharma AG is pleased to announce that it has been awarded a Start-up Innovation Project grant from Innosuisse. With this funding, Innosuisse is supporting a Proof-of-Concept, Phase 2a clinical trial in patients with digital ulcers (DU) in systemic sclerosis (SSc).The grant of...